The RNase a superfamily: Generation of diversity and innate host defense

Molecular Diversity

Volumn 10, Issue 4, 2006, Pages 585-597

  Dyer, Kimberly D ^a   Rosenberg, Helene F ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Angiogenin; Antibacterial; Antihelminth; Antiviral; Cytotoxin; Eosinophils

Indexed keywords

ANGIOTENSIN; ANTIINFECTIVE AGENT; CATION; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; RIBONUCLEASE; RIBONUCLEASE A; RNASE 7;

AMINO ACID SEQUENCE; ANIMAL BEHAVIOR; ANTIBACTERIAL ACTIVITY; BLOOD VESSEL; COW; DEFENSE MECHANISM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ISOLATION; ENZYME STRUCTURE; EOSINOPHIL; FROG; GENE LOCATION; GENETIC VARIABILITY; HOST RESISTANCE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SEMINAL VESICLE; SKIN; VASCULARIZATION;

ANIMALS; CATTLE; ENDORIBONUCLEASES; EVOLUTION, MOLECULAR; HUMANS; IMMUNITY, NATURAL; MULTIGENE FAMILY; PHYLOGENY; RIBONUCLEASE, PANCREATIC; RIBONUCLEASES; SKIN;

EID: 33845351359     PISSN: 13811991     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11030-006-9028-2     Document Type: Review

References (148)

1. Hirs, C.H.W., Moore, S. and Stein, W.H., A chromatographic investigation of pancreatic ribonuclease, J. Biol. Chem., 200 (1953) 493-506.
2. Anfinsen, C.B., Part I. Crystalline pancreatic ribonuclease. Introductory remarks, Ann. N.Y. Acad. Sci., 81 (1959) 513-514.
3. Crestfield, A.M., Stein, W.H. and Moore, S., On the preparation of bovine pancreatic Ribonuclease A, J. Biol. Chem., 238 (1963) 618-621.
4. Smyth, D.G., Stein, W.H. and Moore, S., The sequence of amino acid residues in bovine pancreatic ribonuclease: revisions and confirmations, J. Biol. Chem., 238 (1963) 227-234.
5. Hantgan, R.R., Hammes, G.G. and Scheraga, H.A., Pathways of folding of reduced bovine pancreatic ribonuclease, Biochemistry, 13 (1974) 3421-1331.
6. Scheraga, H.A., Structural studies of pancreatic ribonuclease, Fed. Proc., 26 (1967) 1380-1387.
7. Beers, R.F. Jr., Hydroysis of polyadenylic acid by pancreatic ribonuclease, J. Biol. Chem., 235 (1960) 2393-2398.
8. Walter, B. and Wold, F., The role of lysine in the action of bovine pancreatic Ribonuclease A, Biochemistry, 15 (1976) 304-310.
9. Roth, J.S., Ribonuclease activity and cancer: a review, 23 (1963) 657-666.
10. Reddi, K.K. and Holland, J.F., Elevated serum ribonuclease in patients with pancreatic cancer, Proc. Natl. Acad. Sci. U.S.A., 73 (1976) 2308-2310.
11. Maor, D. and Mardiney, M.R. Jr., Alteration of human serum ribonuclease activity in malignancy, CRC Crit. Rev. Clin. Lab. Sci., 10 (1978) 89-111.
12. Peterson, L.M., Serum RNase in the diagnosis of pancreatic carcinoma, Proc. Natl. Acad. Sci. U.S.A., 76 (1979) 2630-2634.
13. Corbishley, T.P., Greenway, B., Johnson, P.J. and Williams, R., Serum ribonuclease in the diagnosis of pancreatic carcinoma and in monitoring chemotherapy, Clin. Chim. Acta., 124 (1982) 225-233.
14. Isaacs, P., Non-specificity of elevated serum ribonuclease as a pancreatic tumour marker, Digestion, 22 (1981) 101-107.
15. Doran, G., Allen-Mersh, T.G. and Reynolds, K.W., Ribonuclease as a tumour marker for pancreatic carcinoma, J. Clin. Pathol., 33 (1980) 1212-1213.
16. Hidaka, Y., Kimura, M., Izumi, Y., Takano, T., Tatsumi, K.I. and Amino, N., Increased serum concentration of eosinophil-derived neurotoxin in patients with Graves' disease, Thyroid, 13 (2003) 129-132.
17. Ye, B., Skates, S., Horick, N.K., Rosenberg, H.F., Vitonis, A., Berkowitz, R.S., Mok, S.C. and Cramer, D.W., Proteomic-based discovery and characterization of glycosylated eosinophil-derived-neurotoxin and c-terminal osteopontin fragments for ovarian cancer in urine, Clinical Cancer Research, (2005) in press.
18. Kuroi, K. and Toi, M., Circulating angiogenesis regulators in cancer patients, Int. J. Biol. Markers, 16 (2001) 5-26.
19. Zhao, H., Grossman, H.B., Delclos, G.L., Swang, L.Y., Troisi, C.L., Chamberlain, R.M., Chenoweth, M.A., Zhang, H., Spitz, M.R. and Wu, X., Increased plasma levels of angiogenin and the risk of bladder carcinoma: from intiation to recurrence, Cancer, 104 (2005) 30-35.
20. Pavel, M.E., Hassler, G., Baum, U., Hahn, E.G., Lohmann, T. and Schuppan, D., Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas, Clin. Endocrinol., 62 (2005) 434-443.
21. Koutroubakis, I.E., Xidakis, C., Karmiris, K., Sfiridaki, A., Kandidaki, E. and Kouroumalis, E.A., Serum angiogenin in inflammatory bowel disease, Dig. Dis. Sci., 49 (2004) 1758-1762.
22. Steff, A.M., Gagne, D., Page, M., Rioux, A., Hugo, P. and Gosselin, D., Serum concentrations of insulin-like growth factor-1, soluble tumor necrosis factor receptor-1 and angiogenin in endometriosis patients, Am. J. Reprod. Immunol., 51 (2004) 166-173.
23. Beintema, J.J., Gaastra, W., Lenstra, J.A., Welling, G.W. and Fitch, W.M., The molecular evolution of pancreatic ribonuclease, J. Mol. Evol., 10 (1977) 49-71.
24. Beintema, J.J., Fitch, W.M. and Carsana, A., Molecular evolution of pancreatic-type ribonucleases, Mol. Biol. Evol., 3 (1986) 262-275.
25. Beintema, J.J., Ribonucleases in ruminants, 297 (2002) 1121-1122.
26. Beintema, J.J., Introduction: the ribonuclease A superfamily, Cell Mol. Life Sci., 54 (1998) 763-765.
27. Zhou, H.M. and Strydom, D.J., The amino acid sequence of human ribonuclease 4, a highly conserved ribonuclease that cleaves specifically on the 3′ side of uridine, Eur. J. Biochem., 217 (1993) 401-410.
28. Seno, M., Futami, J., Tsushima, Y., Akutagawa, K., Kosaka, M., Tada, H. and Yamada, H., Molecular cloning and expression of human ribonuclease 4 cDNA, Biochim. Biophys. Acta., 1261 (1995) 424-426.
29. Harder, J. and Schroder, J.M., RNase 7, a novel innate immune defense an antimicrobial protein of healthy human skin, J. Biol. Chem., 277 (2002) 46779-46784.
30. Zhang, J., Dyer, K.D. and Rosenberg, H.F., Human RNase 7: a new cationic ribonuclease of the RNase A superfamily, Nucl. Acids Res., 31 (2003) 602-607.
31. Dyer, K.D. and Rosenberg, H.F., Molecular cloning and characterization of a novel human ribonuclease (RNase k6): increasing diversity in the enlarging ribonuclease gene family, Nucleic Acids Res., 24 (1996) 3507-3513.
32. Zhang, J., Dyer, K.D. and Rosenberg, H.F., RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta, Nucl. Acids Res., 30 (2002) 1169-1175.
33. Cho, S., Beintema, J.J. and Zhang, J., The Ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories, Genomics, 85 (2005) 208-220.
34. Penttinen, J., Pujianto, D.A., Sipila, P., Huhtaniemi, I. and Poutanen, M., Discovery in silico and characterization in vitro of novel genes exclusively expressed in the mouse epididymis, Mol. Endocrinol., 17 (2003) 2138-2151.
35. Devor, E.J., Moffat-Wilson, K.A. and Galbraith, J.J., LOC 390443 (RNase 9) on chromosome 14q11.2 is related to the RNase superfamily and contains a unique amino-terminal preproteinlike sequence, Hum. Biol., 76 (2004) 921-935.
36. Castella, S., Fouchecourt, S., Teixeira-Gomes, A.P., Vinh, J., Belghazi, M., Dacheux, F. and Dacheux, J.L., Identification of a member of a new RNase A family, specifically secreted by epididymal caput epithelium, Biol. Reprod., 70 (2004) 319-328.
37. Castella, S., Benedetti, H., de Llorens, R., Dacheux, J.L. and Dacheux, F., Train A, an RNase A-like protein without RNase activity, is secreted and reabsorbed by the same epididymal cells under testicular control, Biol. Reprod., 71 (2004) 1677-1687.
38. Rosenberg, H.F., Eosinophils. In: Gallin, J.I. et al. (Eds.), Inflammation: Basic Principles and Clinical Correlates, 3rd edn, Raven Press Ltd., New York, NY, (1999) pp. 65-76.
39. Rosenberg, H.F., The eosinophil ribonucleases, Cell Mol. Life Sci., 54 (1998) 795-803.
40. Rosenberg, H.F. and Domachowske, J.B., Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens, J. Leukoc Biol., 70 (2001) 691-698.
41. Olsson, I. and Venge, P., Cationic proteins of human granulocytes. I. Isolation of the cationic proteins from the granules of leukaemic myeloid cells, Scand. J. Haematol., 9 (1972) 204-214.
42. Olsson, I. and Venge, P., Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukaemic myeloid cells, Blood, 44 (1974) 235-246.
43. Ackerman, S.J., Gleich, G.J., Loegering, D.A., Richardson, B.A. and Butterworth, A.E., Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni, Am. J. Trop. Med. Hyg., 34 (1985) 735-745.
44. Hamann, K.J., Barker, R.L., Loegering, D.A. and Gleich, G.J., Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis, J. Parasitol., 73 (1987) 523-529.
45. Hamann, K.J., Gleich, G.J., Checkel, J.L., Loegering, D.A., McCall, J.W. and Barker, R.L., In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins, J. Immunol., 144 (1990) 3166-3173.
46. Molina, H.A., Kierszenbaum, F., Hamann, K.J. and Gleich, G.J., Toxic effects produced or mediated by human eosinophil granule components on Trypansoma cruzi, Am. J. Trop. Med. Hyg., 38 (1988) 327-334.
47. McClaren, D.J., McKean, J.R., Olsson, I., Venge, P. and Kay, A.B., Morphological studies on the killling of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro, Parasite Immunol., 3 (1981) 359-373.
48. Yazdanbakhsh, M., Tai, P.C., Spry, C.J., Gleich, G.J. and Roos, D., Synergism between eosinophil cationic protein and oxygen metabolites in killing of schistosomula of Schistosoma mansoni, J. Immunol., 138 (1987) 3443-3447.
49. Waters, L.S., Taverne, J., Tai, P.C., Spry, C.J., Targett, G.A. and Playfair, J.H., Killing of Plasmodium falciparum by eosniophil secretory protducts, Infect Immun., 55 (1987) 877-881.
50. Klion, A.D. and Nutman, T.B., The role of eosinophils in host defense against helminth parasites, J. Allergy Clin. Immunol., 113 (2004) 30-37.
51. Lee, J.J. and Lee, N.A., Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function? Clin. Exp. Allergy, 35 (2005) 986-994.
52. Lehrer, R.I., Szklarek, D., Barton, A., Ganz, T., Hamann, K.J. and Gleich, G.J., Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein, J. Immunol., 142 (1989) 4428-4434.
53. Durack, D.T., Ackerman, S.J., Loegering, D.A. and Gleich, G.J., Purification of human eosinophil-derived neurotoxin, Proc. Natl. Acad. Sci. U.S.A., 76 (1981) 1443-1447.
54. Yang, D., Rosenberg, H.F., Chen, Q., Dyer, K.D., Kurosaka, K. and Oppenheim, J.J., Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells, Blood, 102 (2003) 3396-3403.
55. Yang, D., Chen, Q., Rosenberg, H.F., Rybak, S.M., Newton, D.L., Wang, Z.Y., Fu, Q., Tchernev, V.T., Wang, M., Schweitzer, B., Kingsmore, S.F., Patel, D.D., Oppenheim, J.J. and Howard, O.M., Human ribonuclease A superfamily members eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation, J. Immunol., 173 (2004) 6134-6142.
56. Oppenheim, J.J. and Yang, D., Alarmins: chemotactic activators of immune responses, Curr. Opin. Immunol., 17 (2005) 359-365.
57. Sorrentino, S., Tucker, G.K. and Glitz, D.G., Purification and characterization of a Ribonuclease from human liver, J. Biol. Chem., 263 (1988) 16125-16131.
58. Kauffman, H.F., Hovenga, H., de Bruijn, H.W. and Beintema, J.J., Eosinophil derived neurotoxin (EDN) levels in commercial human urinary preparations of glycoprotein hormones, Eur. J. Obstet. Gynecol. Reprod. Biol., 82 (1999) 111-113.
59. Gleich, G.J., Loegering, D.A., Bell, M.P., Checkel, J.L., Ackerman, S.J. and McKean, D.J., Biochemical and functional similariies between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease, Proc. Natl. Acad. Sci. U.S.A., 83 (1986) 3146-3150.
60. Hamann, K.J., Barker, R.L., Loegering, D.A., Pease, L.R. and Gleich, G.J., Sequence of human eosinophil-derived neurotoxin cDNA: identity of deduced amino acid sequence with human non-secretory ribonucleases, Gene, 83 (1989) 161-167.
61. Rosenberg, H.F., Ackerman, S.J. and Tenen, D.G., Human eosinophil cationic protein: molecular cloning of a cytotoxin and helminthotoxin with riobnuclease activity, J. Exp. Med., 170 (1989) 163-176.
62. Rosenberg, H.F., Tenen, D.G. and Ackerman, S.J., Molecular cloning of human eosinophil-derived neurotoxin: a member of the ribonuclease gene family, Proc. Natl. Acad. Sci. U.S.A., 86 (1989) 4460-4464.
63. Barker, R.L., Loegering, D.A., Ten, R.M., Hamann, K.J., Pease, L.R. and Gleich, G.J., Eosinophil cationic protein cDNA: comparison with other toxic cationic proteins and ribonucleases, J. Immunol., 143 (1989) 952-955.
64. Slifman, N.R., Loegering, D.A., McKean, D.J. and Gleich, G.J., Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein, J. Immunol., 137 (1986) 2913-2917.
65. Gullberg, U., Widegren, B., Arivason, U., Egesten, A. and Olsson, I., The cytotoxic eosinophil cationic protein (ECP) has ribonuclease activity, Biochem. Biophys. Res. Commun., 139 (1986) 1239-1242.
66. Libonati, M. and Sorrentino, S., Revisiting the action of bovine ribonuclease A and pancreatic type ribonucleases on double-stranded RNA, Mol. Cell Biochem., 117 (1992) 139-151.
67. Sorrentino, S. and Libonati, M., Human pancreatic-type and non-pancreatic-type ribonucleases: a direct side-by-side comparison of their catalytic properties, Arch. Biochem. Biophys., 312 (1994) 340-348.
68. Rosenberg, H.F., Recombinant eosinophil cationic protein (ECP): Ribonuclease activity is not essential for cytoxicity, J. Biol. Chem., 270 (1995) 7876-7881.
69. Young, J.D., Peterson, C.G., Venge, P. and Cohn, Z.A., Mechanism of membrane damage mediated by human eosinophil cationic protein, Nature, 321 (1986) 613-616.
70. Rosenberg, H.F., Dyer, K.D., Tiffany, H.L. and Gonzalez, M., Rapid evolution of a unique family of primate ribonuclease genes, Nature Genetics, 10 (1995) 219-223.
71. Zhang, J., Rosenberg, H.F. and Nei, M., Positive Darwinian selection after gene duplication in primate ribonuclease genes, Proc. Natl. Acad. Sci. U.S.A., 95 (1998) 3708-3713.
72. Zhang, J. and Rosenberg, H.F., Complementary advantageous substitutions in the evolution of an antiviral RNase of higher primates, Proc. Natl. Acad. Sci. U.S.A., 99 (2002) 5486-5491.
73. Rosenberg, H.F. and Dyer, K.D., Eosinophil cationic protein and eosinophil-derived neurotoxin: evolution of novel function in a primate ribonuclease gene family, J. Biol. Chem., 270 (1995) 21530-21544.
74. Larson, K.A., Olson, E.V., Madden, B.J., Gleich, G.J., Lee, N.A. and Lee, J.J., Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily, Proc. Natl. Acad. Sci. U.S.A., 3 (1996) 12370-12375.
75. Zhang, J., Dyer, K.D. and Rosenberg, H.F., Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection, Proc. Natl. Acad. Sci. U.S.A., 97 (2000) 4701-4706.
76. Cormier, S.A., Yuan, S., Crosby, J.R., Protheroe, C.A., Dimina, D.M., Hines, E.M., Lee, N.A. and Lee, J.J., T(H)2-mediated pulmonary inflammation leads to the differential expression of ribonuclease genes by alveolar macrophages, Am. J. Respir. Cell Mol. Biol., 27 (2002) 678-687.
77. Garvey, T.L., Dyer, K.D., Ellis, J.A., Bonville, C.A., Foster, B., Prussin, C., Easton, A.J., Domachowske, J.B. and Rosenberg, H.F., Inflammatory responses to pneumovirus infection in IFN-alphabetaR gene-deleted mice, J. Immunol., 175 (2005) 4735-4744.
78. Nitto, T., Dyer, K.D., Mejia, R.A., Bystrom, J., Wynn, T.A. and Rosenberg, H.F., Characterization of the divergent eosinophil ribonuclease, mEar 6, and its expression in response to Schistosoma mansoni infection in vivo, Genes Immun., 5 (2004) 668-674.
79. Lee-Huang, S., Huang, P.L., Sun, Y., Huang, P.L., Kung, H.F., Blithe, D.L. and Chen, H.C., Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin, Proc. Natl. Acad. Sci. U.S.A., 96 (1999) 2678-2681.
80. Rugeles, M.T., Trubey, C.M., Bedoya, V.I., Pinto, L.A., Oppenheim, J.J., Rybak, S.M. and Shearer, G.M., Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition, AIDS., 17 (2003) 481-486.
81. Garofalo, R., Kimpen, J.L., Welliver, R.C. and Ogra, P.L., Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection, J. Pediatr., 120 (1992) 28-35.
82. Colocho Zelaya, E.A., Orvell, C. and Strannegard, O., Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus, Pediatr. Allergy Immunol., 5 (1994) 100-106.
83. Sigurs, N., Bjarnason, R. and Sigurbergsson, F., Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy, Acta. Paediatr., 83 (1994) 1151-1155.
84. Harrison, A.M., Bonville, C.A., Rosenberg, H.F. and Domachowske, J.B., Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation, Am. J. Respir. Crit. Care Med., 159 (1999) 1918-1924.
85. Domachowske, J.B., Dyer, K.D., Bonville, C.A. and Rosenberg, H.F., Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus, J. Infect Dis., 177 (1998) 1458-1464.
86. Rosenberg, H.F., Bonville, C.A., Easton, A.J. and Domachowske, J.B., The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention, Pharmacol. Ther., 105 (2005) 1-6.
87. Easton, A.J., Domachowske, J.B. and Rosenberg, H.F., Animal pneumoviruses: molecular genetics and pathogenesis, Clin. Microbiol. Rev., 17 (2004) 390-412.
88. Zhang, J. and Rosenberg, H.F., Sequence variation at two eosinophil-associated ribonuclease loci in humans, Genetics, 156 (2000) 1949-1958.
89. Kim, Y.J., Kumaraswami, V., Choi, E., Mu, J., Follmann, D.A., Zimmerman, P. and Nutman, T.B., Genetic polymorphisms of eosinophil-derived neurotoxin and eosinophil cationic protein in tropical pulmonary eosinophilia, Am. J. Trop. Med. Hyg., 73 (2005) 125-130.
90. Breukelman, H.J., van der Munnik, N., Kleineidam, R.G., Furia, A. and Beintema, J.J., Secretory ribonuclease genes and pseudogenes in true ruminants, Gene, 212 (1998) 259-268.
91. Fett, J.W., Strydom, D.J., Lobb, R.R., Alderman, E.M., Bethune, J.L., Riordan, J.F., et al., Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells, Biochemistry, 24 (1985) 5480-5486.
92. Strydom, D.J., Fett, J.W., Lobb, R.R., Alderman, E.M., Bethune, J.L., Riordan, J.F., et al., Amino acid sequence of human tumor derived angiogenin, Biochemistry, 24 (1985) 5486-5494.
93. Kurachi, K., Davie, E.W., Strydom, D.J., Riordan, J.F. and Vallee, B.L., Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor, Biochemistry, 24 (1985) 5494-5499.
94. Buolamwini, J.K., Novel anticancer drug discovery, Curr. Opin. Chem. Biol., 3 (1999) 500-509.
95. Riordan, J.F. and Vallee, B.L., Organogenesis and angiogenin, Cell Mol. Life Sci., 53 (1997) 803-815.
96. Loverix, S. and Steyaert, J., Ribonucleases: from prototypes to therapeutic targets, Curr. Med. Chem., 10 (2003) 1241-1253.
97. Leland, P.A., Staniszewski, K.E., Park, C., Kelemen, B.R. and Raines, R.T., The ribonucleolytic activity of angiogenin, Biochemistry, 41 (2002) 1343-1350.
98. St. Clair, D.K., Rybak, S.M., Riordan, J.F. and Vallee, B.L., Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes, Proc. Natl. Acad. Sci. U.S.A., 84 (1987) 8330-8334.
99. Hallahan, T.W., Shapiro, R. and Vallee, B.L., Dual site model for the organogenic activity of angiogenin, Proc. Natl. Acad. Sci. U.S.A., 88 (1991) 2222-2226.
100. Hu, G.F., Strydom, D.J., Fett, J.W., Riordan, J.F. and Vallee, B.L., Actin is a binding protein for angiogenin, Proc. Natl. Acad. Sci. U.S.A., 90 (1993) 1217-1221.
101. Hu, G.F., Riordan, J.F. and Vallee, B.F., A putative angiogenin receptor in angiogenin-responsive human endothelial cells, Proc. Natl. Acad. Sci. U.S.A., 94 (1997) 2204-2209.
102. Liu, S., Yu, D., Xu, Z.P., Riordan, J.F. and Hu, G.F., Angiogenin activated Erk 1/2 in human umbilical vein endothelial cells, Biochem. Biophys. Res. Commun., 287 (2001) 305-310.
103. Kishimoto, K., Liu, S., Tsuji, T., Olson, K.A. and Hu, G.F., Enodgenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis, Oncogene, 24 (2005) 445-456.
104. Hu, G., Xu, C. and Riordan, J.F., Humanangiogenin is rapidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNA, J. Cell Biochem., 76 (2000) 452-462.
105. Nobile, V., Russo, N., Hu, G. and Riordan, J.F., Inhibition of human angiogenin by DNA aptamers: nuclear colocalization of an angiogenin-inhibitor complex, Biochemistry, 37 (1998) 6857-6863.
106. Tsuji, T., Sun, Y., Kishimoto, K., Olson, K.A., Liu, S., Hirukawa, S. and Hu, G.F., Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation, Cancer Res., 65 (2005) 1352-1360.
107. Xu, Z.P., Tsuji, T., Riordan, J.F. and Hu, G.F., The nuclear function of angiogenin in endothelial cells is related to rRNA production, Biochem. Biophys. Res. Commun., 294 (2002) 287-292.
108. Xu, Z.P., Tsuji, T., Riordan, J.F. and Hu, G.F., Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression, Biochemistry, 42 (2003) 121-128.
109. Zhang, J. and Rosenberg, H.F., Diversifying selection of the tumor-growth promoter angiogenin in primate evolution, Mol. Biol. Evol., 19 (2002) 438-445.
110. Zhang, J. and Zhang, Y.P., Pseudogenization of the tumor-growth promoter angiogenin in a leaf-eating monkey, Gene, 308 (2003) 95-101.
111. Cho, S. and Zhang, J., Ancient expansion of the mammalian ribonuclease A superfamily revealed by genomic analysis of placental and marsupial mammals, Gene, In press (2006).
112. Hooper, L.V., Stappenbock, T.S., Hong, C.V. and Gordon, J.I., Angiogenins: a new class of microbicidal proteins involved in innate immunity, Nature Immunol., 4 (2003) 269-273.
113. D'Alessio, G., Di Donato, A., Parente, A. and Piccoli, R., Seminal RNase: a unique member of the ribonuclease superfamily, TIBS, 16 (1991) 104-106.
114. D'Alessio, G., Evolution of oligomeric proteins. The unusual case of a dimeric ribonuclease, Eur. J. Biochem., 266 (1999) 699-708.
115. Libonati, M., Biological actions of the oligomers of ribonuclease A, Cell Mol. Life Sci., 61 (2004) 2431-2436.
116. Libonati, M. and Gotte, G., Oligomerization of bovine ribonuclease A: structural and functional features of its multimers, Biochem. J., 380 (2004) 311-327.
117. Kim, J.S., Soucek, J., Matousek, J. and Raines, R.T., Structural basis for the biological activities of bovine seminal ribonuclease, J. Biol. Chem., 270 (1995) 10525-10530.
118. Bracale, A., Castaldi, F., Nitsch, L. and D'Alessio, G., A role for the intersubunit disulfides of seminal RNase in the mechanism of its antitumor action, Eur. J. Biochem., 270 (2003) 1980-1987.
119. Ciglic, M.I., Jackson, P.J., Raillard, S.A., Haugg, M., Jermann, T.M., Opitz, J.G., Trabesinger-Ruif, N. and Benner, S.A., Origin of the dimeric structure in the ribonuclease superfamily, Biochemistry, 37 (1998) 4008-4002.
120. Kim, J.S., Soucek, J., Matousek, J. and Raines, R.T., Catalytic activity of bovine seminal ribonuclease is essential for its immunosuppressive and other biological activities, Biochem. J., 308 (1995) 547-550.
121. Opitz, J.G., Ciglic, M.I., Haugg, M., Trautwein-Fritz, K., Raillard, S.A., Jermann, T.M. and Benner, S.A., Origin of the catalytic activity of bovine seminal ribonuclease against double-stranded RNA, Biochemistry, 37 (1998) 4023-4033.
122. Sica, F., Di Fiore, A., Merlino, A. and Mazzarella, L., Structure and stability of the non-covalent swapped dimmer of bovine seminal ribonuclease: an enzyme tailored to evade ribonuclease protein inhibitor, J. Biol. Chem., 279 (2004) 36753-36760.
123. Antignani, A., Naddeo, M., Cubellis, M.V., Russo, A. and D'Alessio, G., Antitumor action of seminal ribonuclease, its dimeric structure and its resistance to the cytosolic ribonuclease inhibitor, Biochemistry, 40 (2001) 3492-3496.
124. Matronicola, M.R., Piccoli, R. and D'Alessio, G., Key extracellular and intracellular steps in the antitumor action of seminal ribonuclease, Eur. J. Biochem., 230 (1995) 242-249.
125. Bracale, A., Spalletti-Cernia, D., Mastonicola, M., Castaldi, F., Mannucci, R., Nitsch, L. and D'Alessio, G., Essential stations in the intracellular pathway of cytotoxic bovine seminal ribonuclease, Biochem. J., 362 (2002) 553-560.
126. Matousek, J., Soucek, J., Slavik, T., Tomanek, M., Lee, J.E. and Raines, R.T., Comprehensive comparison of the cytotoxic activities of onconase and bovine seminal ribonuclease. Comp. Biochem. and Physiol., C136 (2003) 343-356.
127. Viola, M., Libra, M., Callari, D., Sinatra, F., Spada, D., Noto, D., Emmanuele, G., Romano, F., Averna, M., Pezzino, R.M., Stivala, F. and Travali, S., Bovine seminal ribonuclease is cytotoxic for both malignant and normal telomerase-positive cells, Int. J. Oncol., 27 (2005) 1071-1077.
128. Marinov, I. and Soucek, J., Bovine seminal ribonuclease induces in vitro concentration dependent apoptosis in stimulated human lymphocytes and cells from human tumor cell lines, Neoplasma, 47 (2000) 294-298.
129. Sinatra, F., Callari, D., Viola, M., Longombardo, M.T., Patania, M., Litrico, L., Emmanuele, G., Lanteri, E., D'Alessandro, N. and Travali, S., Bovine seminal RNase induces apoptosis in normal proliferating lymphocytes, Int. J. Clin. Lab. Res., 30 (2000) 191-196.
130. Soucek, J., Marinov, I., Benes, J., Hilgert, I., Matousek, J. and Raines, R.T., Immunosppressive activity of bovine seminal ribonuclease and its mode of action, Immunobiology, 195 (1996) 271-285.
131. Kotchetkov, R., Cinatl, J., Krivtchik, A.A., Vogel, J.U., Matousek, J., Pouckova, P., Kornhuber, B., Schwabe, D. and Cinatl, J. Jr., Selective activity of BS-RNase against anaplastic thyroid cancer, Anticancer Res., 21 (2001) 1035-1042.
132. Matousek, J. and Klaudy, J., Qualitative and quantitative analyses of seminal ribonuclease in reproductive tract fluids of bulls, Anim. Reprod. Sci., 30 (1998) 111-118.
133. Slavik, T., Matousek, J., Fulka, J. and Raines, R.T., Effect of bovine seminal ribonuclease and bovine pancreatic ribonuclease A on bovine oocyte maturation, J. Exp. Zool., 287 (2000) 394-399.
134. Kleineidam, R.G., Jekel, P.A., Beintema, J.J. and Situmorang, P., Seminal-type riobnuclease genes in ruminants, sequence conservation without protein expression? Gene, 231 (1999) 147-153.
135. Trabesinger-Ruef, N., Jermann, T., Zankel, T., Durrant, B., Frank, G. and Benner, S.A., Pseudogenes in ribonuclease evolution: a source of new biomacromolecular function? FEBS Letters, 382 (1996) 319-322.
136. Titani, K., Takio, K., Kuwada, M., Nitta, K., Sakakibara, F., Kawauchi, H., et al., Amino acid sequence of a lectin from frog (Rana catesbeiana), Biochemistry, 26 (1987) 2188-2194.
137. Nitta, R., Katayama, N., Okabe, Y., Iwama, M., Watanabe, H., Abe, Y., et al., Primary structure of a Ribonuclease from bullfrog (Rana catesbeiana) liver, J. Biochem. (Tokyo), 106 (1989) 729-735.
138. Ardelt, W., Mikulski, M. and Shogen, K., Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes an d early embryos, J. Biol. Chem., 266 (1991) 245-251.
139. Matousek, J., Ribonucleases and their antitumor activity, Comp. Biochem. Physiol. C Toxicol. Pharmacol., 129 (2001) 175-191.
140. Leland, P.A. and Raines, R.T., Cancer chemotherapy - ribonucleases to the rescue, Chem. Biol., 8 (2001) 405-413.
141. Ardelt, B., Ardelt, W. and Darzynkiewicz, Z., Cytotoxic ribonucleases and RNA interference (RNAi), Cell Cycle., 2 (2003) 22-24.
142. Matousek, J., Soucek, J., Slavik, T., Tomanek, M., Lee, J.E. and Raines, R.T., Comprehensive comparison of the cytotoxic activities of onconase and bovine seminal ribonuclease, Comp. Biochem. and Physiol., C136 (2003) 343-356.
143. Tang, P.C., Huang, H.C., Wang, S.C., Jeng, J.C. and Liao, Y.D., Regulation of ribonuclease expression by estradiol in Rana catesbeiana (Bullfrog), Nucl. Acids Res., 30 (2002) 3286-3293.
144. Rosenberg, H.F., Zhang, J., Liao, Y.-D. and Dyer, K.D., Rapid diversification of RNase A superfamily ribonucleases from the bullfrog, Rana catesbeiana, J. Mol. Evol., 53 (2001) 31-38.
145. Liao, Y.D., Huang, H.C., Leu, Y.J., Wei, C.W., Tang, P.C. and Wang, S.C., Purification and cloning of cytotoxic ribonucleases from Rana catesbeiana (bullfrog), Nucleic Acids Res., 28 (2000) 4097-4104.
146. Kumar, S., Tamura, K. and Nei, M., MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment, Brief Bioinform., 5 (2004) 150-163.
147. Klenova, E.M., Botezato, I., Laudet, V., Goodwin, G.H., Wallace, J.C. and Lobanenkov, V.V., Isolation of a cDNA clone encoding the RNase-superfamily- related gene highly expressed in chicken bone marrow cells, Biochem. Biophys. Res. Commun., 185 (1992) 231-239.
148. Nakano, T. and Graf, T., Identification of genes differentially expressed in two types of v-myb-ransformed avian myelomonocytic cells, Oncogene, 7 (1992) 527-534.